Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosdagrocorat in Rheumatoid Arthritis
NCT00938587Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2009
- Primary completion
- Jul 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of fosdagrocorat in rheumatoid arthritis (RA), sponsored by Pfizer. Started Oct 2009; status: completed.
02
Drugs
fosdagrocorat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00938587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938587.